BSE filing, NSE: ANTHEM. Summary written from the filing by ALFA Finder's alert engine.
Anthem Biosciences Ltd: key numbers
- Share price
- ₹832.15
- Market cap
- ₹46,866 Cr
- Revenue (annual)
- ₹2,124 Cr
- Net profit (annual)
- ₹591.8 Cr
- P/E (TTM)
- 81.4×Sector 46.1×
- Promoter holding
- 71.40%-0.02% QoQ
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anthem Biosciences Ltd
All →Anthem Biosciences Other Announcement
Anthem Biosciences Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. The filing provides the current distribution of promoter and public shareholdings.
Anthem Biosciences Other Announcement
Designated Person Viridity Tone LLP sold shares of Anthem Biosciences Ltd worth ₹82.67 Crore via market sale.
- Value
- ₹82.67 Cr
Anthem Biosciences Legal & Regulatory
Anthem Biosciences Ltd announced the settlement of an upside sharing amount of ₹127.68 Crore related to a prior divestment, following shareholder approval.
- Value
- ₹127.7 Cr
Anthem Biosciences Management Change
Anthem Biosciences appointed S.R. Batliboi & Associates LLP as Statutory Auditor and noted director changes, including a rotation and continuation of directorship.
Anthem Biosciences Annual General Meeting
Anthem Biosciences held its 20th AGM on July 22, 2026. Shareholders approved all business resolutions, including financial statements, dividend declaration, and statutory auditor appointments.
Anthem Biosciences Earnings Call Transcript: Key Takeaways
Revenue fell 25% YoY due to deferred deliveries, though management claims a record order book will drive second-half recovery. While EBITDA margins remain high at 39.6%, the quarter reflects high lumpiness in the CRDMO business.
Other board meeting date announcements
All →Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.
Shivam Autotech Board Meeting Date
Shivam Autotech has scheduled a board meeting on 04-11-2026 to consider unaudited standalone results for the quarter ended September 2026. The trading window closes from 01-10-2026 to 06-11-2026.
Moneyview Board Meeting Date
Moneyview will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year. No financial figures are disclosed in this notice.
Abans Enterprises Board Meeting Date
Abans Enterprises will hold a board meeting on 4 November 2026 to consider unaudited quarterly and half-year results. No financial figures are disclosed in this notice.
Gloster Board Meeting Date
Gloster Ltd will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the second quarter. No financial figures are disclosed in this notice.
NRB Bearings Board Meeting Date
NRB Bearings will hold a board meeting on 4 November 2026 to approve Q2 and H1 unaudited results and consider an interim dividend. The trading window stays closed until 9 November 2026.